Se recomienda no prescribir benzodiacepinas en población adolescente de 10 a 21 años ante problemas de ansiedad o insomnio, exceptuando los problemas neurológicos o psiquiátricos graves.

Walter HJ, Bukstein OG, Abright AR, et al. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. J Am Acad Child Adolesc Psychiatry. [Internet.] 2020;59:1107-1124. [Consultado el 29/01/2022]. Disponible en: https://www.jaacap.org/article/S0890-8567(20)30280-X/fulltext

Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005170. doi: 10.1002/14651858.CD005170.pub2.